These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11032992)

  • 21. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation.
    Bell EC; Willson MC; Wilman AH; Dave S; Asghar SJ; Silverstone PH
    Hum Psychopharmacol; 2005 Mar; 20(2):87-96. PubMed ID: 15651051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium-induced decrease of brain inositol and increase of brain inositol-1-phosphate is transient.
    Hirvonen MR; Savolainen K
    Neurochem Res; 1991 Aug; 16(8):905-11. PubMed ID: 1664916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone (GnRH) rapidly stimulates the formation of inositol phosphates and diacyglycerol in rat granulosa cells: further evidence for the involvement of Ca2+ and protein kinase C in the action of GnRH.
    Davis JS; West LA; Farese RV
    Endocrinology; 1986 Jun; 118(6):2561-71. PubMed ID: 3009164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    McGrath BM; McKay R; Dave S; Seres P; Weljie AM; Slupsky CM; Hanstock CC; Greenshaw AJ; Silverstone PH
    Neurosci Res; 2008 Aug; 61(4):351-9. PubMed ID: 18508145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis.
    Vaden DL; Ding D; Peterson B; Greenberg ML
    J Biol Chem; 2001 May; 276(18):15466-71. PubMed ID: 11278273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
    Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nordidemnin potently inhibits inositol uptake in cultured astrocytes and dose-dependently augments lithium's proconvulsant effect in vivo.
    Wolfson M; Einat H; Bersudsky Y; Berkin V; Belmaker RH; Hertz L
    J Neurosci Res; 2000 Apr; 60(1):116-21. PubMed ID: 10723074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a crystal-clear view of lithium's site of action.
    Baraban JM
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5738-9. PubMed ID: 8016061
    [No Abstract]   [Full Text] [Related]  

  • 29. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.
    Moore GJ; Bebchuk JM; Parrish JK; Faulk MW; Arfken CL; Strahl-Bevacqua J; Manji HK
    Am J Psychiatry; 1999 Dec; 156(12):1902-8. PubMed ID: 10588403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder.
    van Calker D; Belmaker RH
    Bipolar Disord; 2000 Jun; 2(2):102-7. PubMed ID: 11252649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.
    Silverstone PH; Asghar SJ; O'Donnell T; Ulrich M; Hanstock CC
    World J Biol Psychiatry; 2004 Jan; 5(1):38-44. PubMed ID: 15048634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?
    Lubrich B; van Calker D
    Neuropsychopharmacology; 1999 Oct; 21(4):519-29. PubMed ID: 10481836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral lithium, inositol and inositol monophosphates.
    Hirvonen MR
    Pharmacol Toxicol; 1991 Jul; 69(1):22-7. PubMed ID: 1658767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs.
    Agam G; Shamir A; Shaltiel G; Greenberg ML
    Bipolar Disord; 2002; 4 Suppl 1():15-20. PubMed ID: 12479670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo 31P NMR spectroscopy of agonist-stimulated phosphatidylinositol metabolism in cat brain.
    Renshaw PF; Schnall MD; Leigh JS
    Magn Reson Med; 1987 Mar; 4(3):221-6. PubMed ID: 3033424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inositol 1,4,5-trisphosphate accumulation in brain of lithium-treated rats.
    Ishima Y; Fujimagari M; Masuzawa Y; Waku K
    Lipids; 1993 Jul; 28(7):577-81. PubMed ID: 8394976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression.
    Tsuji S; Morinobu S; Tanaka K; Kawano K; Yamawaki S
    J Neural Transm (Vienna); 2003 Apr; 110(4):413-25. PubMed ID: 12658368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis.
    Sherman WR; Munsell LY; Gish BG; Honchar MP
    J Neurochem; 1985 Mar; 44(3):798-807. PubMed ID: 2983019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lithium on phosphoinositide metabolism in vivo.
    Sherman WR; Gish BG; Honchar MP; Munsell LY
    Fed Proc; 1986 Oct; 45(11):2639-46. PubMed ID: 3019784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
    Wolfson M; Bersudsky Y; Zinger E; Simkin M; Belmaker RH; Hertz L
    Brain Res; 2000 Feb; 855(1):158-61. PubMed ID: 10650143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.